Tiden, Journalen och kvalitetsarbetet - Nyttan måste vägas mot kostnaderna

Lakartidningen

Volumn 97, Issue 18, 2000, Pages 2245-2249

  Ericsson, Mats ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE POLICY; HEALTH CARE QUALITY; HOSPITAL MANAGEMENT; HUMAN; MEDICAL RECORD; STANDARD; SWEDEN;

COST-BENEFIT ANALYSIS; HEALTH POLICY; HOSPITAL ADMINISTRATION; HUMANS; MEDICAL RECORDS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; QUALITY ASSURANCE, HEALTH CARE; SWEDEN;

EID: 0034600150     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Microcirculation 1997; 4: 1-23.
2. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-8.
3. Folkman J. Antiangiogenic therapy. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and practice of oncology, 5th ed. Lippincott-Raven, Philadelphia, PA, 1997: 3075-85.
4. Browder T, Butterfield CE, Kräling BM, Shi B, Marshall B, O'Reilly MS et al. Anti-angiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000; 60: 1878-86.
5. Hjarnaa PJ, Jonsson E, Latini S, Dhar S, Larsson R, Bramm E et al. CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo. Cancer Res 1999; 59: 5751-7.